Planning and Evaluation

规划和评价 项目摘要 博士科里为中心设定了总体愿景。为了实现这一点，他从事内部和 外部领导人，委员会和个人，以帮助制定未来的方向，计划和 中心的战略投资。规划是通过正式和非正式两种方式实现的 机制等同样的方法也适用于评价，以便领导层能够评估如何 它有效地实现了中心的目标，并确定中期变化是否 needed.这一规划和评价过程导致了及时和成功的执行 新的战略和变化的组织和癌症研究的方向进行 在财团。 规划和评价的具体目标是： 1.提供一个有效的结构，让所有联盟伙伴参与规划， 评价活动，使机构目标与共同的 癌症研究联盟的目标。 2.支持并最大限度地发挥内部和外部联合体机制的价值 （内部委员会和外部顾问）确定最具战略意义的领域 对联合体及其相关资源要求的重要性，并致力于 足够的领导力和机构及CCSG资金，以取得可衡量的成功。 3.为联合体目标进展的持续评估提供结构。 新项目期间的主要重点领域是进一步开发实体肿瘤 转化研究;改善临床试验支持的协调性和一致性 整个中心;建立生物医学信息学能力;扩大研究， 以及建立癌症研究能力 健康经济学、全球肿瘤学和肥胖症。 4.通过以下方式，使联合会成员参与确定新的科学机会领域： 提供CCSG和其他资金，以支持科学研讨会和讲习班， 新兴研究领域。

PLANNING AND EVALUATION Project Summary Dr. Corey sets the overarching vision for the center. To accomplish this he engages internal and external leaders, committees and individuals to help chart the future directions, plans and strategic investments for the center. Planning is achieved through both formal and informal mechanisms. The same approach is applied to evaluation, so that leadership can assess how effectively it is achieving the center's goals and determine whether mid-course changes are needed. This planning and evaluation process has led to timely and successful implementation of new strategies and changes in the organization and direction of cancer research conducted at the Consortium. The Specific Aims of Planning and Evaluation are to: 1. Provide an effective structure that engages all Consortium partners in planning and evaluation activities such that institutional objectives are well aligned with common Consortium cancer research objectives. 2. Support and maximize the value of internal and external Consortium mechanisms (internal committees and external advisors) to identify areas of greatest strategic importance to the Consortium and their associated resource requirements, and dedicate sufficient leadership and institutional and CCSG funds to achieve measurable success. 3. Provide structure for ongoing evaluation of progress toward Consortium objectives. Major areas of emphasis during the new project period are to further develop solid tumor translational research; improve coordination and consistency of clinical trials support across the center; build biomedical informatics capabilities; expand research in the catchment area and with underserved populations; and build research capacity in cancer health economics, global oncology and obesity. 4. Engage Consortium members in identifying new areas of scientific opportunity, through provision of CCSG and other funds to support scientific symposia and workshops on emerging research areas.